NASDAQ:CNXC

Concentrix (NASDAQ: CNXC) Q2 Earnings: A Deep Dive into Financial Performance and Market Position

Font: Financial Modeling Prep  • Jun 30, 2026

Market Chart
  • Concentrix reported an earnings per share (EPS) of $2.63, slightly missing the analyst consensus estimate of $2.64.
  • Despite a narrow miss on estimates, quarterly revenue grew by 1.9% year-over-year, reaching $2.46 billion.
  • The company maintains sound financial health with a Debt-to-Equity ratio of 0.24 and a current ratio of 1.18.

Concentrix (NASDAQ: CNXC) is a global provider of customer experience services and technologies. The company helps other businesses manage their customer interactions and business processes. It operates in a competitive market, offering solutions that aim to improve customer engagement and operational efficiency for its clients worldwide.

On June 29, 2026, Concentrix reported its second-quarter financial results. The company announced an earnings per share (EPS) of $2.63, which was slightly below the analyst consensus estimate of $2.64. This performance also represents a decrease from the $2.70 per share reported in the same quarter one year ago.

For the same quarter, Concentrix posted revenue of $2.46 billion. This figure narrowly missed the consensus estimate of $2.47 billion by 0.43%, as highlighted by Zacks. Despite the miss, this revenue shows a 1.9% increase compared to the $2.42 billion reported in the prior-year quarter, according to GlobeNewswire. The company's Price-to-Sales ratio, which compares its stock price to its revenues, stands at 0.15.

The company's financial health shows a Debt-to-Equity ratio of 0.24, indicating it has more equity than debt financing its assets. Its current ratio is 1.18. This metric suggests that Concentrix has $1.18 in current assets for every $1 of current liabilities, showing it can cover its short-term obligations.

Market Overview
NIVF
NewGenIvf Group Limited
$0.17
133.33%
RETO
ReTo Eco-Solutions, Inc.
$0.11
26.15%
FNGR
FingerMotion, Inc.
$0.18
28.25%
TGE
Generation Essentials Group
$1.55
86.75%
CNTB
Connect Biopharma Holdings Limited
$1.10
10.89%
NVDA
NVIDIA Corporation
$228.38
0.51%
AEON
AEON Biopharma, Inc.
$0.30
15.83%
NU
Nu Holdings Ltd.
$12.66
2.51%
INTC
Intel Corp.
$120.23
3.71%
NVD
GraniteShares 2x Short NVDA Daily ETF
$3.64
-0.55%